Striving for more reliable study results?
We focus on quality.

Associate members

The SCTO is an independent organisation and is based on a joint initiative of the Swiss National Science Foundation and the Swiss Academy of Medical Sciences.

As of 2017, the SCTO is a research infrastructure of national importance funded by the State Secretariat of Education, Research and Innovation and the Swiss National Science Foundation.

SCTO Platforms

Pools of expertise in key areas of clinical research

The SCTO Platforms serve different clients with a range of needs. As pools of expertise, our platforms aim to be the first point of contact when questions arise regarding any topic related to clinical research. 

To optimise clinical research, our platforms focus on eight key fields: auditing, data management, education, monitoring, project managementregulatory affairssafety, and statistics and methodology. We will publish regular updates on the objectives and output of these platforms as they continue to develop.

To find out more about our platforms, please consult the fact sheet below on this page.

Who is behind the platforms?

Each Clinical Trial Unit (CTU) of our CTU Network runs a platform, and each platform includes staff from all CTUs. Furthermore, the Swiss Group for Clinical Cancer Research (SAKK) also contributes by running the Safety Platform and participating in the majority of the platforms. The cantonal hospital network Ente Ospedaliero Cantonale (EOC) too contributes to most of the platforms and represents the Italian-speaking region of Switzerland as an SCTO associate member. Further stakeholders and external experts may be invited to join the platforms for specific topics.

Each SCTO platform is run by one or more coordinators: 



Dr Anja Eskat and Dr Nicole Leisinger, CTU Zurich

Data Management 

Dr Patrick Wright, CTU Basel

Education  Dr Melanie Glättli, SCTO Executive Office
Monitoring Dr Jocelyne Chabert, CTU Geneva
Project Management Dr Synove Otterbech and Dr Simone Kälin, CTU St.Gallen
Regulatory Affairs Dr Laure Vallotton, CTU Lausanne
Safety Dr Daniela Hauser, Swiss Group for Clinical Cancer Research (SAKK)
Statistics & Methodology Brigitta Gahl, CTU Bern